{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:55:55Z","timestamp":1791093355687,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T00:00:00Z","timestamp":1324339200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T00:00:00Z","timestamp":1324339200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1038\/leu.2011.360","type":"journal-article","created":{"date-parts":[[2011,12,20]],"date-time":"2011-12-20T12:00:22Z","timestamp":1324382422000},"page":"985-990","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":111,"title":["Inhibition of CXCR4 in CML cells disrupts their interaction with the bone marrow microenvironment and sensitizes them to nilotinib"],"prefix":"10.1038","volume":"26","author":[{"given":"E","family":"Weisberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K","family":"Azab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P W","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Kung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A L","family":"Christie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I M","family":"Ghobrial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J D","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,20]]},"reference":[{"key":"BFleu2011360_CR1","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/S1470-2045(10)70233-3","volume":"11","author":"FX Mahon","year":"2010","unstructured":"Mahon FX, Rea D, Guilhot J, Guilhot F, Huguet F, Nicolini F et al. Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 yeras: the prospective, multicentre Stop Imatinib (STIM) trial. Lancet Oncol 2010; 11: 1029\u20131035.","journal-title":"Lancet Oncol"},{"key":"BFleu2011360_CR2","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1182\/blood-2011-02-335497","volume":"118","author":"J-C Chomel","year":"2011","unstructured":"Chomel J-C, Bonnet M-L, Sorel N, Bertrand A, Meunier M-C, Fichelson S et al. Leukemic stem cell persistence in chronic myeloid leukemia patients with sustained undetectable molecular residual disease. Blood 2011; 118: 3657\u20133660.","journal-title":"Blood"},{"key":"BFleu2011360_CR3","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1038\/sj.leu.2405086","volume":"22","author":"H Konig","year":"2008","unstructured":"Konig H, Holtz M, Modi H, Manley P, Holyoake TL, Forman SJ et al. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia 2008; 22: 748\u2013755.","journal-title":"Leukemia"},{"key":"BFleu2011360_CR4","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1172\/JCI118474","volume":"97","author":"M Kumagai","year":"1996","unstructured":"Kumagai M, Manabe A, Pui CH, Behm FG, Raimondi SC, Hancock ML et al. Stroma-supported culture in childhood B-lineage acute lymphoblastic leukemia cells predicts treatment outcome. J Clin Invest 1996; 97: 755\u2013760.","journal-title":"J Clin Invest"},{"key":"BFleu2011360_CR5","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0145-2126(94)90017-5","volume":"18","author":"DM Ashley","year":"1994","unstructured":"Ashley DM, Bol SJ, Kannourakis G . Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts. Leuk Res 1994; 18: 337\u2013346.","journal-title":"Leuk Res"},{"key":"BFleu2011360_CR6","first-page":"813","volume":"10","author":"K Bradstock","year":"1996","unstructured":"Bradstock K, Bianchi A, Makrynikola V, Filshie R, Gottlieb D . Long-term survival and proliferation of precursor B acute lymphoblastic leukemia cells on human bone marrow stroma. Leukemia 1996; 10: 813\u2013820.","journal-title":"Leukemia"},{"key":"BFleu2011360_CR7","doi-asserted-by":"publisher","first-page":"375","DOI":"10.3109\/10428199709058305","volume":"27","author":"S Rafii","year":"1997","unstructured":"Rafii S, Mohle R, Shapiro F, Frey BM, Moore MA . Regulation of hematopoiesis by microvascular endothelium. Leuk Lymphoma 1997; 27: 375\u2013386.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2011360_CR8","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1182\/blood.V91.7.2387","volume":"91","author":"L Lagneaux","year":"1998","unstructured":"Lagneaux L, Delforge A, Bron D, De Bruyn C, Stryckmans P . Chronic lymphocytic leukemic B cells but not normal B cells are rescued from apoptosis by contact with normal bone marrow stromal cells. Blood 1998; 91: 2387\u20132396.","journal-title":"Blood"},{"key":"BFleu2011360_CR9","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/10428199909169609","volume":"35","author":"L Lagneaux","year":"1999","unstructured":"Lagneaux L, Delforge A, De Bruyn C, Bernier M, Bron D . Adhesion to bone marrow stroma inhibits apoptosis of chronic lymphocytic leukemia cells. Leukemia Lymphoma 1999; 35: 445\u2013453.","journal-title":"Leukemia Lymphoma"},{"key":"BFleu2011360_CR10","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/sj.leu.2402608","volume":"16","author":"M Konopleva","year":"2002","unstructured":"Konopleva M, Konoplev S, Hu W, Zaritskey AY, Afanasiev BV, Andreeff M . Stromal cells prevent apoptosis of AML cells by up-regulation of anti-apoptotic proteins. Leukemia 2002; 16: 1713\u20131724.","journal-title":"Leukemia"},{"key":"BFleu2011360_CR11","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ajh.10092","volume":"70","author":"C Litwin","year":"2002","unstructured":"Litwin C, Leong KG, Zapf R, Sutherland H, Naiman SC, Karsan A . Role of the microenvironment in promoting angiogenesis in acute myeloid leukemia. Am J Hematol 2002; 70: 22\u201330.","journal-title":"Am J Hematol"},{"key":"BFleu2011360_CR12","doi-asserted-by":"publisher","first-page":"4341","DOI":"10.1182\/blood-2008-10-186668","volume":"113","author":"AK Azab","year":"2009","unstructured":"Azab AK, Runnels JM, Pitsillides C, Moreau AS, Azab F, Leleu X et al. CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy. Blood 2009; 113: 4341\u20134351.","journal-title":"Blood"},{"key":"BFleu2011360_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1182\/blood-2009-01-199281","volume":"114","author":"AK Azab","year":"2009","unstructured":"Azab AK, Azab F, Blotta S, Pitsillides CM, Thompson B, Runnels JM et al. RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma. Blood 2009; 114: 619\u2013629, (IF=10.5).","journal-title":"Blood"},{"key":"BFleu2011360_CR14","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1158\/1078-0432.CCR-10-2772","volume":"17","author":"AK Azab","year":"2011","unstructured":"Azab AK, Azab F, Maiso P, Quang P, Roccaro AM, Sacco A et al. FGFR3 is overexpressed in Waldenstr\u00f6m macroglobulinemia and its inhibition by Dovitinib induces apoptosis, and overcomes stroma-induced proliferation. Clin Cancer Res 2011; 17: 4389\u20134399.","journal-title":"Clin Cancer Res"},{"key":"BFleu2011360_CR15","doi-asserted-by":"crossref","unstructured":"Azab F, Azab AK, Maiso P, Calimeri T, Flores LM, Liu Y et al. Eph-B2\/ephrin-B2 interaction plays a major role in the adhesion and proliferation of Waldenstrom's Macroglobulinemia. Clin Cancer Res 2011; e-pub ahead of print 18 October 2011.","DOI":"10.1158\/1078-0432.CCR-11-0111"},{"key":"BFleu2011360_CR16","unstructured":"Azab AK, Quang P, Azab F, Pitsillides C, Tompson B, Chonghaile T et al. P-selectin glycoprotein ligand regulates the interaction of multiple myeloma cells with the bone marrow microenvironment. Blood 2011; e-pub ahead of print 16 November 2011."},{"key":"BFleu2011360_CR17","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1182\/blood.V82.7.2045.2045","volume":"82","author":"CM Verfaillie","year":"1993","unstructured":"Verfaillie CM . Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 1993; 82: 2045\u20132053.","journal-title":"Blood"},{"key":"BFleu2011360_CR18","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/0145-2126(95)00171-9","volume":"20","author":"JL Liesveld","year":"1996","unstructured":"Liesveld JL, Harbol AW, Abboud CN . Stem cell factor and stromal cell co-culture prevent apoptosis in a subculture of the megakaryoblastic cell line, UT-7. Leuk Res 1996; 20: 591\u2013600.","journal-title":"Leuk Res"},{"key":"BFleu2011360_CR19","first-page":"474","volume":"11","author":"PR Harrison","year":"1997","unstructured":"Harrison PR, Nibbs RJ, Bartholomew C, O\u2019Prey J, Qiu J, Walker M et al. Molecular mechanisms involved in long-term maintenance of erythroleukaemia cells by stromal cells. Leukemia 1997; 11: 474\u2013477.","journal-title":"Leukemia"},{"key":"BFleu2011360_CR20","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.leu.2400530","volume":"11","author":"DA Breems","year":"1997","unstructured":"Breems DA, Blokland EA, Ploemacher RE . Stroma-conditioned media improve expansion of human primitive hematopoietic stem cells and progenitor cells. Leukemia 1997; 11: 42\u201350.","journal-title":"Leukemia"},{"key":"BFleu2011360_CR21","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood.V91.5.1548","volume":"91","author":"J O\u2019Prey","year":"1998","unstructured":"O\u2019Prey J, Leslie N, Itoh K, Ostertag W, Bartholomew C, Harrison PR . Both stroma and stem cell factor maintain long-term growth of ELM erythroleukemia cells, but only stroma prevents erythroid differentiation in response to erythropoietin and interleukin-3. Blood 1998; 91: 1548\u20131555.","journal-title":"Blood"},{"key":"BFleu2011360_CR22","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood.V92.12.4798","volume":"92","author":"NR Leslie","year":"1998","unstructured":"Leslie NR, O\u2019Prey J, Bartholomew C, Harrison PR . An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin. Blood 1998; 92: 4798\u20134807.","journal-title":"Blood"},{"key":"BFleu2011360_CR23","first-page":"623","volume":"94","author":"CC Shih","year":"1999","unstructured":"Shih CC, Hu MC, Hu J, Medeiros J, Forman SJ . Long-term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells. Blood 1999; 94: 623\u2013636.","journal-title":"Blood"},{"key":"BFleu2011360_CR24","doi-asserted-by":"publisher","first-page":"4500","DOI":"10.1182\/blood-2004-08-3210","volume":"105","author":"Y Shaked","year":"2005","unstructured":"Shaked Y, Cervi D, Neuman M, Chen L, Klement G, Michaud CR et al. The splenic microenvironment is a source of proangiogenesis\/inflammatory mediators accelerating the expansion of murine erythroleukemic cells. Blood 2005; 105: 4500\u20134507.","journal-title":"Blood"},{"key":"BFleu2011360_CR25","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1634\/stemcells.2005-0530","volume":"24","author":"G Despars","year":"2006","unstructured":"Despars G, O\u2019Neill HC . Splenic endothelial cell lines support development of dendritic cells from bone marrow. Stem Cells 2006; 24: 1496\u20131504.","journal-title":"Stem Cells"},{"key":"BFleu2011360_CR26","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1158\/1535-7163.MCT-07-2331","volume":"7","author":"E Weisberg","year":"2008","unstructured":"Weisberg E, Wright RD, McMillin DW, Mitsiades C, Ray A, Barrett R et al. Stromal-mediated protection of tyrosine kinase inhibitor-treated BCR-ABL-expressing leukemia cells. Mol Cancer Ther 2008; 7: 1121\u20131129.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2011360_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1158\/1535-7163.MCT-07-0042","volume":"7","author":"L Jin","year":"2008","unstructured":"Jin L, Tabe Y, Konoplev S, Xu Y, Levsath CE, Lu H et al. CXCR4 up-regulation by imatinib induces chronic myelogenous leukemia (CML) cell migration to bone marrow stroma and promotes survival of quiescent CML cells. Mol Cancer Ther 2008; 7: 48\u201358.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2011360_CR28","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.1158\/0008-5472.CAN-04-2152","volume":"65","author":"JF Geay","year":"2005","unstructured":"Geay JF, Buet D, Zhang Y, Foudi A, Jarrier P, Berthebaud M et al. p210BCR-ABL inhibits SDF-1 chemotactic response via alteration of CXCR4 signaling and down-regulation of CXCR4 expression. Cancer Res 2005; 65: 2676\u20132683.","journal-title":"Cancer Res"},{"key":"BFleu2011360_CR29","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1080\/10428190903150847","volume":"50","author":"F Dillmann","year":"2009","unstructured":"Dillmann F, Veldwijk MR, Laufs S, Sperandio M, Calandra G, Wenz F et al. Plerixafor inhibits chemotaxis toward SDF-1 and CXCR4-mediated stroma contact in a dose-dependent manner resulting in increased susceptibility of BCR-ABL+ cell to Imatinib and Nilotinib. Leuk Lymphoma 2009; 50: 1676\u20131686.","journal-title":"Leuk Lymphoma"},{"key":"BFleu2011360_CR30","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1158\/1535-7163.MCT-06-0228","volume":"5","author":"Z Zeng","year":"2006","unstructured":"Zeng Z, Samudio IJ, Munsell M, An J, Huang Z, Estey E et al. Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias. Mol Cancer Ther 2006; 5: 3113\u20133121.","journal-title":"Mol Cancer Ther"},{"key":"BFleu2011360_CR31","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1124\/mol.108.053389","volume":"75","author":"I Kalatskaya","year":"2009","unstructured":"Kalatskaya I, Berchiche Y, Gravel S, Limberg B, Rosenbaum J, Heveker N . AMD3100 is a CXCR7 ligand with allosteric agonist properties. Molecular Pharmocology 2009; 75: 1240\u20131247.","journal-title":"Molecular Pharmocology"},{"key":"BFleu2011360_CR32","doi-asserted-by":"publisher","first-page":"6206","DOI":"10.1182\/blood-2008-06-162123","volume":"113","author":"B Nervi","year":"2009","unstructured":"Nervi B, Ramirez P, Rettig MP, Uy GL, Holt MS, Ritchey JK et al. Chemosensitization of acute myeloid leukemia (AML) following mobilization by the CXCR4 antagonist AMD3100. Blood 2009; 113: 6206\u20136214.","journal-title":"Blood"},{"key":"BFleu2011360_CR33","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1182\/blood-2006-07-035857","volume":"109","author":"Y Alsayed","year":"2007","unstructured":"Alsayed Y, Ngo H, Runnels J, Leleu X, Singha UK, Pitsillides CM et al. Mechanisms of regulation of CXCR4\/SDF1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 2007; 109: 2708\u20132717.","journal-title":"Blood"},{"key":"BFleu2011360_CR34","first-page":"1460","volume":"21","author":"U Matulonis","year":"1993","unstructured":"Matulonis U, Salgia R, Okuda K, Druker B, Griffin JD . IL-3 and p210 BCR-ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line. Exp Hematol 1993; 21: 1460\u20131466.","journal-title":"Exp Hematol"},{"key":"BFleu2011360_CR35","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ccr.2005.01.007","volume":"7","author":"E Weisberg","year":"2005","unstructured":"Weisberg E, Manley PW, Breitenstein W, Br\u00fcggen J, Cowan-Jacob SW, Ray A et al. Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl. Cancer Cell 2005; 7: 129\u2013141.","journal-title":"Cancer Cell"},{"key":"BFleu2011360_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S1535-6108(03)00003-5","volume":"3","author":"SA Armstrong","year":"2003","unstructured":"Armstrong SA, Kung AL, Mabon ME, Silverman LB, Stam RW, Den Boer ML et al. Validation of a therapeutic target identified by gene expression based classification. Cancer Cell 2003; 3: 173\u2013183.","journal-title":"Cancer Cell"},{"key":"BFleu2011360_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.exphem.2009.12.003","volume":"38","author":"A Jacobi","year":"2010","unstructured":"Jacobi A, Thieme S, Lehmann R, Ugarte F, Malech HL, Koch S et al. Impact of CXCR4 inhibition on FLT3-ITD-positive human AML blasts. Exp Hematol 2010; 38: 180\u2013190.","journal-title":"Exp Hematol"},{"key":"BFleu2011360_CR38","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1016\/j.leukres.2007.02.017","volume":"31","author":"JL Liesveld","year":"2007","unstructured":"Liesveld JL, Bechelli J, Rosell K, Lu C, Bridger G, Phillips II G et al. Effects of AMD3100 on transmigration and survival of acute myelogenous leukemia cells. Leuk Res 2007; 31: 1553\u20131563.","journal-title":"Leuk Res"},{"key":"BFleu2011360_CR39","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.3324\/haematol.2009.017178","volume":"95","author":"F Vianello","year":"2010","unstructured":"Vianello F, Villanova F, Tisato V, Lymperi S, Ho K-K, Gomes AR et al. Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4\/CXCL12 axis. Haematologica 2010; 95: 1081\u20131089.","journal-title":"Haematologica"},{"key":"BFleu2011360_CR40","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/leu.2010.212","volume":"24","author":"E Weisberg","year":"2010","unstructured":"Weisberg E, Ray A, Barrett R, Nelson E, Christie AL, Porter D et al. Smac mimetics: implications for enhancement of targeted therapies in leukemia. Leukemia 2010; 24: 2100\u20132109.","journal-title":"Leukemia"},{"key":"BFleu2011360_CR41","doi-asserted-by":"crossref","unstructured":"Agarwal A, Fleischman AG, Petersen CL, Loriaux MM, Woltjer R, Druker BJ et al. Effects of Plerixafor (AMD3100) in Combination with Tyrosine Kinase Inhibition in a Murine Mouse Model of CML. Abstract #3389. 52nd ASH Annual Meeting and Exposition. Dec 4-7, 2010.","DOI":"10.1182\/blood.V116.21.3389.3389"},{"key":"BFleu2011360_CR42","doi-asserted-by":"crossref","unstructured":"Burrell K . Role of bone marrow derived cells in response to ionizing radiation in normal brain. Abstract #566. AACR 2011.","DOI":"10.1158\/1538-7445.AM2011-566"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2011360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011360","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2011360.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:40:14Z","timestamp":1648737614000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2011360"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,20]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["BFleu2011360"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.360","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,20]]},"assertion":[{"value":"9 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}